Dr. Sameer Farouk Sait
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Cerebral Gliomas
Studies Brain Tumor
10 reported clinical trials
19 drugs studied
Area of expertise
1Cerebral Gliomas
Stage I
Stage II
NF1 positive
2Brain Tumor
NF1 positive
BRAF positive
ARAF positive
Affiliated Hospitals
Clinical Trials Sameer Farouk Sait is currently running
Avutometinib
for Solid Tumors
The purpose of this study is to find out whether avutometinib is a safe treatment for advanced or recurrent solid tumor cancers in children and young adults. Researchers will look for the highest dose of avutometinib that is safe and cause few or mild side effects.
Recruiting1 award Phase 137 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
More about Sameer Farouk Sait
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sameer Farouk Sait has experience with
- Radiation Therapy
- Selumetinib
- Avutometinib
- Neratinib
- Vinblastine Sulfate
- Selumetinib Sulfate
Breakdown of trials Sameer Farouk Sait has run
Cerebral Gliomas
Brain Tumor
Uterine Tumors
Fibrillary Astrocytoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sameer Farouk Sait specialize in?
Sameer Farouk Sait focuses on Cerebral Gliomas and Brain Tumor. In particular, much of their work with Cerebral Gliomas has involved Stage I patients, or patients who are Stage II.
Is Sameer Farouk Sait currently recruiting for clinical trials?
Yes, Sameer Farouk Sait is currently recruiting for 4 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Sameer Farouk Sait has studied deeply?
Yes, Sameer Farouk Sait has studied treatments such as Radiation Therapy, Selumetinib, Avutometinib.
What is the best way to schedule an appointment with Sameer Farouk Sait?
Apply for one of the trials that Sameer Farouk Sait is conducting.
What is the office address of Sameer Farouk Sait?
The office of Sameer Farouk Sait is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.